API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Tertomotide [inn]
2. Unii-55r7rg342o
3. 55r7rg342o
4. Gv 1001
5. Gv-1001
6. 915019-08-8
7. Human Telomerase Reverse Transcriptase (ec 2.7.7.49)-(611-626)-peptide (telomerase Catalytic Subunit Fragment)
Molecular Weight | 1868.2 g/mol |
---|---|
Molecular Formula | C85H146N26O21 |
XLogP3 | -7.6 |
Hydrogen Bond Donor Count | 25 |
Hydrogen Bond Acceptor Count | 26 |
Rotatable Bond Count | 60 |
Exact Mass | 1867.11558577 g/mol |
Monoisotopic Mass | 1867.11558577 g/mol |
Topological Polar Surface Area | 779 Ų |
Heavy Atom Count | 132 |
Formal Charge | 0 |
Complexity | 3910 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 18 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Tertomotide is a peptide vaccine that activates the immune system so that it recognises and kills cancer cells.
Tertomotide targets an enzyme called telomerase. Telomerase is seldom found in normal cell types but is overexpressed in most cancer cells.